380 related articles for article (PubMed ID: 31257247)
1. [Prion-like Propagation of Pathological α-Synuclein in Vivo].
Masuda-Suzukake M; Hasegawa M
Yakugaku Zasshi; 2019; 139(7):1007-1013. PubMed ID: 31257247
[TBL] [Abstract][Full Text] [Related]
2. [Animal models of synucleinopathies: prion-like propagation of alpha-synuclein in wild-type animals].
Masuda-Suzukake M
Nihon Yakurigaku Zasshi; 2019; 154(6):301-305. PubMed ID: 31787680
[TBL] [Abstract][Full Text] [Related]
3. Propagation of pathological α-synuclein in marmoset brain.
Shimozawa A; Ono M; Takahara D; Tarutani A; Imura S; Masuda-Suzukake M; Higuchi M; Yanai K; Hisanaga SI; Hasegawa M
Acta Neuropathol Commun; 2017 Feb; 5(1):12. PubMed ID: 28148299
[TBL] [Abstract][Full Text] [Related]
4. Pathological alpha-synuclein propagates through neural networks.
Masuda-Suzukake M; Nonaka T; Hosokawa M; Kubo M; Shimozawa A; Akiyama H; Hasegawa M
Acta Neuropathol Commun; 2014 Aug; 2():88. PubMed ID: 25095794
[TBL] [Abstract][Full Text] [Related]
5. Common Marmoset Model of α-Synuclein Propagation.
Masuda-Suzukake M; Shimozawa A; Hashimoto M; Hasegawa M
Methods Mol Biol; 2021; 2322():131-139. PubMed ID: 34043199
[TBL] [Abstract][Full Text] [Related]
6. Robust Central Nervous System Pathology in Transgenic Mice following Peripheral Injection of α-Synuclein Fibrils.
Ayers JI; Brooks MM; Rutherford NJ; Howard JK; Sorrentino ZA; Riffe CJ; Giasson BI
J Virol; 2017 Jan; 91(2):. PubMed ID: 27852849
[TBL] [Abstract][Full Text] [Related]
7. Prion-like propagation of human brain-derived alpha-synuclein in transgenic mice expressing human wild-type alpha-synuclein.
Bernis ME; Babila JT; Breid S; Wüsten KA; Wüllner U; Tamgüney G
Acta Neuropathol Commun; 2015 Nov; 3():75. PubMed ID: 26612754
[TBL] [Abstract][Full Text] [Related]
8. Prion-like spreading of pathological α-synuclein in brain.
Masuda-Suzukake M; Nonaka T; Hosokawa M; Oikawa T; Arai T; Akiyama H; Mann DM; Hasegawa M
Brain; 2013 Apr; 136(Pt 4):1128-38. PubMed ID: 23466394
[TBL] [Abstract][Full Text] [Related]
9. Prion-like propagation of α-synuclein in neurodegenerative diseases.
Tarutani A; Hasegawa M
Prog Mol Biol Transl Sci; 2019; 168():323-348. PubMed ID: 31699325
[TBL] [Abstract][Full Text] [Related]
10. The effect of truncation on prion-like properties of α-synuclein.
Terada M; Suzuki G; Nonaka T; Kametani F; Tamaoka A; Hasegawa M
J Biol Chem; 2018 Sep; 293(36):13910-13920. PubMed ID: 30030380
[TBL] [Abstract][Full Text] [Related]
11. Is Multiple System Atrophy a Prion-like Disorder?
Jellinger KA; Wenning GK; Stefanova N
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576255
[TBL] [Abstract][Full Text] [Related]
12. Alpha-synuclein spreading in M83 mice brain revealed by detection of pathological α-synuclein by enhanced ELISA.
Bétemps D; Verchère J; Brot S; Morignat E; Bousset L; Gaillard D; Lakhdar L; Melki R; Baron T
Acta Neuropathol Commun; 2014 Mar; 2():29. PubMed ID: 24624994
[TBL] [Abstract][Full Text] [Related]
13. Localized Induction of Wild-Type and Mutant Alpha-Synuclein Aggregation Reveals Propagation along Neuroanatomical Tracts.
Ayers JI; Riffe CJ; Sorrentino ZA; Diamond J; Fagerli E; Brooks M; Galaleldeen A; Hart PJ; Giasson BI
J Virol; 2018 Sep; 92(18):. PubMed ID: 29976670
[TBL] [Abstract][Full Text] [Related]
14. Prion-like propagation of pathology in Parkinson disease.
Volpicelli-Daley L; Brundin P
Handb Clin Neurol; 2018; 153():321-335. PubMed ID: 29887143
[TBL] [Abstract][Full Text] [Related]
15. Toxic properties of microsome-associated alpha-synuclein species in mouse primary neurons.
Colla E; Panattoni G; Ricci A; Rizzi C; Rota L; Carucci N; Valvano V; Gobbo F; Capsoni S; Lee MK; Cattaneo A
Neurobiol Dis; 2018 Mar; 111():36-47. PubMed ID: 29246724
[TBL] [Abstract][Full Text] [Related]
16. Comparative analyses of the in vivo induction and transmission of α-synuclein pathology in transgenic mice by MSA brain lysate and recombinant α-synuclein fibrils.
Dhillon JS; Trejo-Lopez JA; Riffe C; Levites Y; Sacino AN; Borchelt DR; Yachnis AY; Giasson BI
Acta Neuropathol Commun; 2019 May; 7(1):80. PubMed ID: 31109378
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the in vivo induction and transmission of α-synuclein pathology by mutant α-synuclein fibril seeds in transgenic mice.
Rutherford NJ; Dhillon JS; Riffe CJ; Howard JK; Brooks M; Giasson BI
Hum Mol Genet; 2017 Dec; 26(24):4906-4915. PubMed ID: 29036344
[TBL] [Abstract][Full Text] [Related]
18. Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy.
Schaser AJ; Stackhouse TL; Weston LJ; Kerstein PC; Osterberg VR; López CS; Dickson DW; Luk KC; Meshul CK; Woltjer RL; Unni VK
Acta Neuropathol Commun; 2020 Aug; 8(1):150. PubMed ID: 32859276
[TBL] [Abstract][Full Text] [Related]
19. Collusion of α-Synuclein and Aβ aggravating co-morbidities in a novel prion-type mouse model.
Lloyd GM; Dhillon JS; Gorion KM; Riffe C; Fromholt SE; Xia Y; Giasson BI; Borchelt DR
Mol Neurodegener; 2021 Sep; 16(1):63. PubMed ID: 34503546
[TBL] [Abstract][Full Text] [Related]
20. Anti-aggregation Effects of Phenolic Compounds on α-synuclein.
Ono K; Tsuji M; Yamasaki TR; Pasinetti GM
Molecules; 2020 May; 25(10):. PubMed ID: 32456274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
